$110.00
ARA 290 is a non-erythropoietic peptide that offers neuroprotection, pain relief, anti-inflammation, and tissue repair, especially for neuropathy.
25 in stock
The only component in ARA 290 is a non-linear with an 11-amino acid peptide, as referred to by PHBSP, Cibinetide, and Helix surface peptide.
ARA 290 peptide is investigated for neuropathic pain associated with type 2 diabetes, sarcoidosis, and small nerve fibre loss.
Studies focus on the ARA 290 peptide for its ability to reduce inflammation and improve survival after myocardial infarction, and reduce organ dysfunction in haemorrhage models.
The research has suggested ARA 290 for its potential in diabetic retinopathy and mitigating the neuroinflammation by acting on the CNS.
It selectively binds with IRR, or ARA 290, as it triggers the tissue protective and anti-inflammatory signalling pathways for the production of red blood cells.
It reduces the production of the pro-inflammatory cytokines like TNF, IL-1, and IL-6 in the context of injury and metabolic stress.
In neuropathic pain, the ARA 290 suppresses the spinal microglia and the astrocyte as it reduces the neuroinflammation in the spinal cord.
It promotes the fibre regrowth along with structural damage in diabetic neuropathy in small fibre neuropathy.
The research indicates that ARA 290 will improve neuropathic symptoms like pain, tingling and allodynia as it helps in metabolic control.
The studies have shown that the mouse models in which the cerebral artery has been studied have shown that ARA 290 will reduce the brain infarction and neuronal apoptosis.
Studies focus on its effect on macrophages, decreasing pro-inflammatory cytokine production (e.g., TNF-α, IL-1β, IL-6).
The research has shown protection against organ dysfunction in experimental models along with acute kidney injury.
Note : Please review and adhere to our Terms and Conditions before ordering
Tesamorelin(10mg) is a synthetic growth hormone-releasing hormone (GHRH) analog developed to stimulate endogenous growth hormone (GH) secretion. It is FDA-approved for reducing excess abdominal (visceral) fat in patients with HIV-associated lipodystrophy. By increasing GH and IGF-1 levels, Tesamorelin promotes lipolysis while preserving lean body mass. It is also being investigated for broader metabolic and fat-reduction benefits, including potential applications in non-HIV-related obesity and non-alcoholic fatty liver disease (NAFLD).
| Quantity | 10mg |
|---|
N Acetyl Selank (10mg) is a synthetic peptide derived from Selank, which itself is an analogue of the human tuftsin peptide. This acetylated version is designed for enhanced stability and potency, offering nootropic, anxiolytic, and neuroprotective benefits. It modulates key neurotransmitters like serotonin, dopamine, and GABA, and has been researched for its effects on anxiety reduction, mood stabilization, cognitive enhancement, and immune regulation.
| Quantity | 10mg |
|---|
GLP-1 R activates GLP-1, GIP, and glucagon receptors and is used in laboratory research to study metabolic pathways, receptor activity, and peptide interactions. Compounds like this are commonly studied in preclinical and research settings to explore potential therapeutic mechanisms.
| Quantity | 16mg, 24mg |
|---|
DSIP 5mg is a compound for managing insomnia, reducing anxiety, supporting physical recovery, and providing neuroprotection. It acts on delta brain wave activity and influences the endocrine system, making it a valuable compound in research for managing insomnia, reducing anxiety, supporting physical recovery, and providing neuroprotection. DSIP is under research, especially for its usefulness in sleep disturbances, chronic stress, or neurodegenerative studies.
| Quantity | 5mg |
|---|
